Rutgers University boosts next-generation sequencing sample access

The Rutgers University Cell and DNA Repository (RUCDR; Piscataway, NJ), the largest cell and DNA biobank in the US, has adopted PerkinElmer's (Waltham, MA) technologies for automation of next-generation sequencing (NGS) sample preparation.

Next-generation sequencing research could greatly advance knowledge and facilitate data sharing in identifying the causes of disease, in developing potential disease therapies, as well as in possible clinical diagnostic innovations. Combining the company's sample library automation with Rutgers' biorepository will make millions of biological samples accessible to researchers worldwide, helping to enable large-scale genomic and disease-related studies.

The company's NGS laboratory pipeline preparation solutions will enable the RUCDR to perform quality control (QC) on 25,000 DNA samples per week, and prepare hundreds of DNA and RNA sequence libraries per week.

With the partnership, RUCDR will have the capacity to prepare every biological sample coming into the repository for automated sequencing applications. This will help expedite research projects, ensure comparable data quality across analytical centers, and facilitate large-scale access and use of clinically relevant samples across a variety of NIH-, foundation-, and industry-funded projects, according to Dr. Andrew Brooks, associate professor of genetics and chief operating officer at RUCDR.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Follow OptoIQ on your iPhone; download the free app here.

Subscribe now to BioOptics World magazine; it's free!